Placebo News and Research

RSS

Study: Aspirin is not recommended for people who never had a heart attack or stroke

If you've never had a heart attack or stroke, you likely should not be taking aspirin to prevent them, according to new research.

3 Oct 2019

Laser therapy can be safe and effective in treating vaginal problems, study suggests

Nearly 50% of menopausal women complain of vaginal dryness, itching, and burning, among other commonly reported menopause symptoms. Laser therapy is one of the newer techniques for addressing these problems.

2 Oct 2019

Diet low in fermented carbohydrates improves health-related quality of life in IBD patients

New research from King's College London has found that a diet low in fermented carbohydrates has improved certain gut symptoms and improved health-related quality of life for sufferers of inflammatory bowel disease (IBD).

2 Oct 2019

Vitamin C improves survival rate in sepsis and acute respiratory distress syndrome (ARDS)

The body’s immune system works by protecting against disease and potentially damaging foreign bodies. In some instances, it may become impaired, leading to overreaction to infection.

1 Oct 2019

MedStar Heart & Vascular Institute enrolls first patient in cardiac stem cell clinical study

MedStar Heart & Vascular Institute has enrolled its first patient to a clinical trial to determine whether cardiac stem cells reduce inflammation enough to improve heart function in patients with heart failure severe enough to require a left ventricular assist device, or LVAD.

1 Oct 2019

New study demonstrates benefits of omega-3 on the heart

Researchers have published results of the largest trial of omega-3 to date, demonstrating a role for omega-3 supplements in lowering the risk of heart attack and CVD.

1 Oct 2019

Analyses of two clinical trials predict response to asthma drug by COPD patients

Chronic obstructive pulmonary disease, or COPD, is the third leading cause of death in the U.S., according to the American Lung Association.

30 Sep 2019

Intensive new combination therapy for ovarian cancer shows promising results

Researchers have found that more intensive chemotherapy maintenance for ovarian cancer could be beneficial for patients. The results of the study were presented at the ESMO Congress 2019 in Barcelona, Spain last weekend on the 28th of September.

30 Sep 2019

Placebos may lead to mistaken inferences about effects and harms of new treatment

Placebo controls are the 'gold' standard against which new treatments are often measured. If a new treatment consistently proves to be better than a placebo treatment, then it is taken to be effective. Otherwise, it isn't.

30 Sep 2019

Nintedanib drug can benefit patients with broad range of scarring lung diseases

Nintedanib, a medication approved for the treatment of idiopathic pulmonary fibrosis, slows the decline in lung function among patients with a broad range of scarring lung diseases.

30 Sep 2019

Combination of two immunotherapy drugs stops or reverses progression of advanced melanoma

A combination of two immunotherapy drugs, ipilimumab and nivolumab, has stopped or reversed the progression of advanced melanoma for five years or more in one in two patients, according to a study led by The Royal Marsden NHS Foundation Trust.

28 Sep 2019

PARP inhibitor combined with chemotherapy increases survival for newly diagnosed ovarian cancer patients

Researchers from The University of Texas MD Anderson Cancer Center reported study results showing that initial treatment with the PARP inhibitor veliparib in combination with chemotherapy significantly increased progression-free survival for patients with newly diagnosed, metastatic high-grade serous ovarian cancer, according to the results of the VELIA trial.

28 Sep 2019

Lipid produced in response to cold helps reduce blood sugar

Researchers based in Brazil, the United States and Germany have discovered that 12-HEPE, a lipid produced in response to cold by brown adipose tissue in the human body, helps reduce blood sugar. The results of their experiments with mice pave the way for new treatments for diabetes.

27 Sep 2019

Ticagrelor monotherapy reduces bleeding while preserving ischemic benefit in high-risk PCI patients

New data from the randomized, placebo-controlled TWILIGHT trial found that compared to ticagrelor plus aspirin, ticagrelor monotherapy reduces bleeding events without increasing the risk of death, myocardial infarction, or stroke in high-risk patients who have undergone successful percutaneous coronary intervention and completed three months of dual antiplatelet therapy.

27 Sep 2019

High-risk heart patients may not require long-term aspirin use after stent placement

High-risk patients undergoing coronary stent procedures may not require long-term aspirin use after stent placement, Mount Sinai researchers report in a groundbreaking study

26 Sep 2019

Clinical trial to evaluate efficacy and safety of new treatment for giant cell arteritis

An international, multicenter phase II clinical trial is evaluating the efficacy and safety of mavrilimumab co-administered with a 26-week corticosteroid taper in patients with giant cell arteritis.

26 Sep 2019

Long-term hormone therapy does more harm than good for men with low PSAs after prostate surgery

A secondary analysis of a recent clinical trial that changed the standard of care for men with recurring prostate cancer finds long-term hormone therapy does more harm than good for many men and calls for rethinking treatment guidelines based on a patient's post-operative prostate-specific antigen (PSA) level.

26 Sep 2019

Researchers use AI to predict depression outcomes

The psychiatry field has long sought answers to explain why antidepressants help only some people.

25 Sep 2019

BCG vaccination in childhood could decrease risk of lung cancer

A common tuberculosis vaccine could decrease the risk of lung cancer if administered during early childhood, according to a study published Sept. 25 in JAMA Network Online.

25 Sep 2019

Cheaper drug equally effective in preserving cardiovascular function in boys with DMD

A new clinical trial conducted at The Ohio State University Wexner Medical Center found a cost-effective generic medication works just as well as a more expensive drug in preserving cardiovascular function in boys with Duchenne muscular dystrophy (DMD).

24 Sep 2019

Placebo News and Research

Study: Aspirin is not recommended for people who never had a heart attack or stroke

Laser therapy can be safe and effective in treating vaginal problems, study suggests

Diet low in fermented carbohydrates improves health-related quality of life in IBD patients

Vitamin C improves survival rate in sepsis and acute respiratory distress syndrome (ARDS)

MedStar Heart & Vascular Institute enrolls first patient in cardiac stem cell clinical study

New study demonstrates benefits of omega-3 on the heart

Analyses of two clinical trials predict response to asthma drug by COPD patients

Intensive new combination therapy for ovarian cancer shows promising results

Placebos may lead to mistaken inferences about effects and harms of new treatment

Nintedanib drug can benefit patients with broad range of scarring lung diseases

Combination of two immunotherapy drugs stops or reverses progression of advanced melanoma

PARP inhibitor combined with chemotherapy increases survival for newly diagnosed ovarian cancer patients

Lipid produced in response to cold helps reduce blood sugar

Ticagrelor monotherapy reduces bleeding while preserving ischemic benefit in high-risk PCI patients

High-risk heart patients may not require long-term aspirin use after stent placement

Clinical trial to evaluate efficacy and safety of new treatment for giant cell arteritis

Long-term hormone therapy does more harm than good for men with low PSAs after prostate surgery

Researchers use AI to predict depression outcomes

BCG vaccination in childhood could decrease risk of lung cancer

Cheaper drug equally effective in preserving cardiovascular function in boys with DMD

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News